Professional Documents
Culture Documents
CHEMOTHERAPY :
Natural Acquired
Bacteria may be
Bacteria can develop
inherently resistant
resistance to antibiotics
to an antibiotic
Gene
Mutation
Transfer
Natural Bacterial Resistance
Right from the time of discovery of the antibiotic, the bacterium dose not respond to the
drug. E.g. Nalidixic acid was discovered in 1964. Since then, it is not active against gram
positive bacteria.
Acquired Resistance
• Bacteria acquire resistance against an antibacterial, which other wise, was effective earlier.
This normally occurs due to change in their DNA.
Changes that results in bacterial resistance are of four types and include:
• a) Modification in the structure and/or number of the drug target site in the bacteria
• b) Changes in the bacterial cell membrane that decreases the ability of the drug to
penetrate the membrane (porin channels)
• c) Production of enzyme that degrade the antibiotic eg Beta-lactamase.
• d) Antibiotic efflux: pumps manufactured by the resistant bacteria cause efflux of
the antibiotics before they can act on their intracellular target sites.
BETA-LACTAMASES AND
BACTERIAL RESISTANCE
-Lactamases hydrolyze the amide bond in the -lactam
ring and prevent the active drug from reaching target
penicillin-binding proteins (PBPs).
• The majority of Gram-negative bacteria, staphylococci,
anaerobes and even mycobacteria produce -
lactamases.
• The most common -lactamases produced by
Enterobacteriaceae, and staphylococcal beta lactamases
are generally plasmid-mediated. These enzymes can be
effectively inhibited by -lactamase inhibitors unless the
latter are overwhelmed by -lactamase hyperproduction.
STRUCTURE OF PENICILLIN
Side chain Β-lactam ring S
C N CHCOO-Na
Amidase O
Thiazolidine ring
Penicillinase/Betalactamase
Hydrolysis of the beta lactam ring by
beta lactamase
Β-lactam ring S
destroyed
R-CH2CO NH-CH CH C(CH3)2
C N CHCOO-Na
O OH
Thiazolidine ring
Penicillinase/Betalactamase
Types of Beta Lactamases:
II Chromosomal Penicillins
IV Chromosomal Both
V Plasmid Penicillins
EXTENDED SPECTRUM BETA LACTAMASES (ESBL):
INHIBITION OF BETA-LACTAMASE
Type I Type II
Topoisomerase-IV
for relaxation &
separation of daughter DNA
MECHANISM OF ACTION OF
ANTIMICROBIAL DRUGS :
MECHANISM OF ACTION OF
ANTIMICROBIAL DRUGS :
Interference with cell wall synthesis
Penicillins, Cephalosporins, Bacitracin, Vancomycin, and Cycloserine.
Antimetabolite action
Sulfonamides, Sulfones, PAS and Trimethoprim.
Antianerobic and antiprotozoal drugs
Secnidazole
Ornidazole